Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | August 03, 2021 08:11am

 

Gainers

  • Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3 million.
  • Translate Bio (NASDAQ:TBIO) stock increased by 29.33% to $37.7. The market value of their outstanding shares is at $2.8 billion.
  • Processa Pharmaceuticals (NASDAQ:PCSA) stock moved upwards by 18.99% to $7.14. The company's market cap stands at $111.1 million.
  • Monopar Therapeutics (NASDAQ:MNPR) stock increased by 17.48% to $6.25. The market value of their outstanding shares is at $78.5 million.
  • Trinity Biotech (NASDAQ:TRIB) stock moved upwards by 12.5% to $2.43. The company's market cap stands at $50.7 million.
  • Cerecor (NASDAQ:CERC) shares increased by 10.03% to $2.96. The market value of their outstanding shares is at $282.5 million.

 

 

Losers

 

  • Protagenic Therapeutics (NASDAQ:PTIX) stock fell 5.83% to $2.1 during Tuesday's pre-market session. The company's market cap stands at $30.7 million.
  • Vanda Pharmaceuticals (NASDAQ:VNDA) stock declined by 5.09% to $16.05. The market value of their outstanding shares is at $892.9 million. As per the press release, Q2 earnings came out 4 days ago.
  • Verastem (NASDAQ:VSTM) shares fell 4.68% to $3.06. The market value of their outstanding shares is at $526.0 million. The company's, Q2 earnings came out yesterday.
  • Exicure (NASDAQ:XCUR) shares decreased by 4.42% to $1.73. The market value of their outstanding shares is at $152.2 million.
  • DBV Technologies (NASDAQ:DBVT) shares decreased by 4.29% to $5.14. The market value of their outstanding shares is at $564.7 million. As per the news, the Q2 earnings report came out yesterday.
  • Histogen (NASDAQ:HSTO) stock decreased by 3.18% to $0.86. The market value of their outstanding shares is at $35.9 million.

 

 

Posted In: CERC DBVT HSTO MNPR OTLK PCSA PTIX TBIO TRIB VNDA VSTM XCUR